ADVERTISEMENT
ADVERTISEMENT
iStock
A Cleaner Clean Room Starts with the CO2 Incubator
Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.
A Cleaner Clean Room Starts with the CO2 Incubator
A Cleaner Clean Room Starts with the CO2 Incubator

Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.

Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.

drug production
Learn how to make cell therapy manufacturing workflows more efficient.
Successful Cell Therapy Manufacturing
Thermo Fisher Scientific | Jul 14, 2022 | 1 min read
Explore what makes an effective and efficient cell therapy manufacturing workflow.
Pharma’s Ghost Labs Find New Life
Katarina Zimmer | Nov 1, 2019 | 10 min read
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
Yeast Engineered to Make Cannabinoids
Kerry Grens | Feb 27, 2019 | 2 min read
Genes inserted into the yeast genome produce the compounds CBD and THC in the microbes.
Solar-Powered Yeast Are More Efficient Drug Factories
Ruth Williams | Nov 15, 2018 | 3 min read
Researchers have outfitted brewer’s yeast with light-harvesting semiconductors to boost chemical productivity.
The Age of Pharmabrewing
Laura Marengo and John D. Loike | Jan 1, 2016 | 3 min read
We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.
Stem Cells Off the Line
Ronnda L. Bartel | Apr 1, 2014 | 3 min read
Researchers work to improve the efficiency of cell therapy manufacturing, while developing procedures to ensure consistent quality.    
 
Pharma Company Sues FDA
Cristina Luiggi | Jul 10, 2012 | 1 min read
The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012 | 5 min read
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
A Bill to Expedite Drug Production
Jef Akst | Feb 2, 2012 | 1 min read
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.
ADVERTISEMENT